Dexmedetomidine Not Yet Recruiting Phase 4 Trials for Remimazolam (DB12404)

IndicationStatusPhase
DBCOND0050052 (Dexmedetomidine)Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05688345Comparison of Recovery Profiles Among Propofol, Remimazolam, and Dexmedetomidine After Intraoperative SedationTreatment